TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned. July 16, 2004